לונסורף 15 מג6.14 מג
medison pharma ltd - tipiracil as hydrochloride; trifluridine - טבליות מצופות פילם - tipiracil as hydrochloride 6.14 mg; trifluridine 15 mg - trifluridine, combinations
לונסורף 15 מג6.14 מג
medison pharma ltd - tipiracil as hydrochloride; trifluridine - טבליות מצופות פילם - tipiracil as hydrochloride 6.14 mg; trifluridine 15 mg - trifluridine, combinations
לונסורף 20 מג8.19 מג
medison pharma ltd - tipiracil as hydrochloride; trifluridine - טבליות מצופות פילם - tipiracil as hydrochloride 8.19 mg; trifluridine 20 mg - trifluridine, combinations
לונסורף 20 מג8.19מג
medison pharma ltd - tipiracil as hydrochloride; trifluridine - טבליות מצופות פילם - tipiracil as hydrochloride 8.19 mg; trifluridine 20 mg - trifluridine, combinations
סימדקו 50 מג75 מג ו-75 מג
vertex pharmaceuticals (u.k) limited, israel - ivacaftor; ivacaftor; tezacaftor - טבליות מצופות פילם - ivacaftor 75 mg; tezacaftor 50 mg; ivacaftor 75 mg - ivacaftor and tezacaftor
לופרסור דיויטבס 200 מג
novartis israel ltd - metoprolol tartrate - טבליות בשחרור איטי - metoprolol tartrate 200 mg - metoprolol - metoprolol - hypertension, angina pectoris, arrhythmia, prophylaxis of migrain, prophylaxis of reinfarction.
זומקטון 10 מג
ferring pharmaceuticals ltd - somatropin - אבקה וממס להכנת תמיסה להזרקה - somatropin 10 mg - somatropin - somatropin - short stature due to pituitary growth hormone deficiency turner's syndrome, children suffering from renal insufficiency. children : short stature due to inadequate or failed secretion of pituitary growth hormone or turner's syndrome. short stature in children with renal insufficiency.
ניופוגן 30 mu בקבוקונים
amgen europe b.v. - filgrastim - תמיסה להזרקה - filgrastim 30 mu/ml - filgrastim - filgrastim - - reduction in the duration and severity of neutropenia in patients treated with highly myelosuppressive chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ).- reduction in the duration of neutropenia in patients undergoing high-dose cytotoxic chemotherapy followed by bone marrow transplantation. - in children or adults with severe congenital neutropenia cyclic neutropenia or idiopathic neutropenia a history of clinically important infections within the last 12 months and three documented episodes of neutropenia (with an anc< 5 x 1000000000) long-term administration of neupogen is indicated to increase neutrophil counts and to reduce infections. - neupogen is indicated for the mobilisation of autologous peripheral blood progenitor cells alone or following myelosuppressive chemotherapy and the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic pbpc).
ניופוגן mu 48 מזרק מוכן לשימוש
amgen europe b.v. - filgrastim - תמיסה להזרקה - filgrastim 48 mu / 0.5 ml - filgrastim - filgrastim - - reduction in the duration and severity of neutropenia in patients treated with highly myelosuppressive chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ).- reduction in the duration of neutropenia in patients undergoing high-dose cytotoxic chemotherapy followed by bone marrow transplantation. - in children or adults with severe congenital neutropenia cyclic neutropenia or idiopathic neutropenia a history of clinically important infections within the last 12 months and three documented episodes of neutropenia (with an anc< 5 x 1000000000) long-term administration of neupogen is indicated to increase neutrophil counts and to reduce infections. - neupogen is indicated for the mobilisation of autologous peripheral blood progenitor cells alone or following myelosuppressive chemotherapy and the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic pbpc).
ניופוגן mu 30 מזרק מוכן לשימוש
amgen europe b.v. - filgrastim - תמיסה להזרקה - filgrastim 30 mu / 0.5 ml - filgrastim - filgrastim - - reduction in the duration and severity of neutropenia in patients treated with highly myelosuppressive chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ).- reduction in the duration of neutropenia in patients undergoing high-dose cytotoxic chemotherapy followed by bone marrow transplantation. - in children or adults with severe congenital neutropenia cyclic neutropenia or idiopathic neutropenia a history of clinically important infections within the last 12 months and three documented episodes of neutropenia (with an anc< 5 x 1000000000) long-term administration of neupogen is indicated to increase neutrophil counts and to reduce infections. - neupogen is indicated for the mobilisation of autologous peripheral blood progenitor cells alone or following myelosuppressive chemotherapy and the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic pbpc).